PTBP1 and cancer: Treatment with miR‐124 activated neuronal differentiation of a mouse cancer cell line by targeting polypyrimidine tract binding protein 1 (PTB1), which in turn increased the expression of a splice variant of PTB2, important for correct splicing of several neuronal genes (Makeyev et al., 2007).